Bio-Techne: William Geist, David Eansor

Bio-Techne has appointed William Geist as president of its protein sciences segment, effective Jan. 3, 2022. Geist was most recently chief operating officer at Quanterix, where he was responsible for enterprise-wide operations and strategy deployment. Previously, he was VP and general manager for Thermo Fisher Scientific's protein and cell analysis and qPCR business units, and VP of Qiagen's QuantaBiosciences.

Geist succeeds David Eansor, who is retiring and will remain with Bio-Techne through the end of February 2022 to ensure a smooth transition.